NuCana (NCNA) Short Interest Ratio & Short Volume $3.44 +0.13 (+3.93%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.39 -0.05 (-1.45%) As of 08/22/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NuCana Short Interest DataNuCana (NCNA) has a short interest of 61,000 shares, representing 290.48% of the float (the number of shares available for trading by the public). This marks a -99.79% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 848,419 shares to cover all short positions.Current Short Interest61,000 sharesPrevious Short Interest29,120,000 sharesChange Vs. Previous Month-99.79%Dollar Volume Sold Short$523.38 thousandShort Interest Ratio0.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares30,000 sharesShort Percent of Float290.48%Today's Trading Volume416,279 sharesAverage Trading Volume848,419 sharesToday's Volume Vs. Average49% Short Selling NuCana? Sign up to receive the latest short interest report for NuCana and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNCNA Short Interest Over TimeNCNA Days to Cover Over TimeNCNA Percentage of Float Shorted Over Time NuCana Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/202561,000 shares $523.38 thousand -99.8%290.5%0 $8.58 7/15/202529,120,000 shares $1.46 million +542.8%N/A0.1 $0.05 6/30/20254,530,000 shares $260.02 thousand -1.7%108.3%0 $0.06 6/15/20254,610,000 shares $529.69 thousand +66.4%80.9%0 $0.11 5/31/20252,770,000 shares $97.23 thousand -9.2%48.6%0 $0.04 5/15/20253,050,000 shares $162.87 thousand +408.1%57.2%0.1 $0.05 4/30/2025600,300 shares $354.18 thousand +5,165.8%11.3%0.1 $0.59 4/15/202511,400 shares $9.74 thousand -90.2%0.2%0.1 $0.85 3/31/2025115,900 shares $101.16 thousand +1,217.1%2.2%1.4 $0.87 3/15/20258,800 shares $6.69 thousand -49.1%0.2%0.1 $0.76 Get the Latest News and Ratings for NCNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NuCana and its competitors with MarketBeat's FREE daily newsletter. 2/28/202517,300 shares $16.78 thousand -2.3%0.5%0.2 $0.97 2/15/202517,700 shares $16.11 thousand -66.9%0.5%0.1 $0.91 1/31/202553,500 shares $54.57 thousand -56.0%1.5%0.4 $1.02 1/15/2025121,700 shares $131.45 thousand -15.7%3.3%0.8 $1.08 12/31/2024144,300 shares $171.72 thousand +73.9%3.9%0.8 $1.19 12/15/202483,000 shares $105.41 thousand +36.5%2.3%0.3 $1.27 11/30/202460,800 shares $79.04 thousand -3.7%1.7%0 $1.30 11/15/202463,100 shares $94.02 thousand -0.6%3.0%0 $1.49 10/31/202463,500 shares $102.87 thousand -35.4%3.0%0 $1.62 10/15/202498,300 shares $184.80 thousand -62.7%4.7%0.1 $1.88 9/30/2024263,600 shares $606.28 thousand +321.8%12.5%0.2 $2.30 9/15/202462,500 shares $158.75 thousand +0.2%3.2%0.1 $2.54 8/31/202462,400 shares $228.38 thousand +41.5%3.2%0.5 $3.66 8/15/202444,100 shares $145.09 thousand -7.9%2.3%0.4 $3.29 7/31/202447,900 shares $174.36 thousand +42.6%2.4%1.7 $3.64 7/15/202433,600 shares $104.16 thousand -2.6%1.7%1.2 $3.10 6/30/202434,500 shares $87.98 thousand +3.0%1.8%1.4 $2.55 6/15/202433,500 shares $100.50 thousand -10.4%1.7%1.3 $3.00 5/31/202437,400 shares $135.01 thousand +16.2%1.9%0.5 $3.61 5/15/202432,200 shares $122.36 thousand +41.9%1.7%0.4 $3.80 4/30/202422,700 shares $91.03 thousand +144.1%1.2%0.3 $4.01 4/15/20249,300 shares $41.39 thousand -94.4%0.5%0.1 $4.45 3/31/2024164,900 shares $42.87 thousand -93.4%0.4%0.1 $0.26 3/15/20242,480,000 shares $864.78 thousand +2,616.3%5.7%1.6 $0.35 2/29/202491,300 shares $29.22 thousand +293.5%0.2%0.6 $0.32 2/15/202423,200 shares $7.31 thousand -29.9%0.1%0.2 $0.32 1/31/202433,100 shares $9.93 thousand -16.2%0.1%0.3 $0.30 1/15/202439,500 shares $11.81 thousand -34.4%0.1%0.4 $0.30 12/31/202360,200 shares $17.81 thousand -32.7%0.1%0.4 $0.30 12/15/202389,500 shares $31.31 thousand -40.9%0.2%0.7 $0.35The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 11/30/2023151,400 shares $62.38 thousand -11.7%0.4%2 $0.41 11/15/2023171,400 shares $70.10 thousand +3.1%0.4%2.5 $0.41 10/31/2023166,200 shares $81.44 thousand +101.2%0.4%2.2 $0.49 10/15/202382,600 shares $55.33 thousand +111.8%0.2%1.1 $0.67 9/30/202339,000 shares $23.79 thousand -26.7%0.1%0.9 $0.61 9/15/202353,200 shares $32.84 thousand -3.5%0.1%1.1 $0.62 8/31/202355,100 shares $39.67 thousand -45.5%0.1%1.1 $0.72 8/15/2023101,100 shares $66.93 thousand +13.1%0.2%2.1 $0.66 7/31/202389,400 shares $67.94 thousand -0.7%0.2%2.2 $0.76 7/15/202390,000 shares $70.38 thousand +23.0%0.2%2.2 $0.78 6/30/202373,200 shares $57.83 thousand -4.3%0.2%1.8 $0.79 6/15/202376,500 shares $57.38 thousand -20.4%0.2%1 $0.75 5/31/202396,100 shares $80.20 thousand +23.2%0.2%1 $0.83 5/15/202378,000 shares $61.93 thousand +67.7%0.2%0.7 $0.79 4/30/202346,500 shares $39.48 thousand -45.0%0.1%0.4 $0.85 4/15/202384,600 shares $75.29 thousand -1.3%0.2%0.7 $0.89 3/31/202385,700 shares $82.28 thousand -27.4%0.2%0.6 $0.96 3/15/2023118,000 shares $142.78 thousand +55.5%0.3%0.8 $1.21 2/28/202375,900 shares $110.06 thousand -1.8%0.2%0.7 $1.45 2/15/202377,300 shares $128.32 thousand +6.0%0.2%0.7 $1.66 1/31/202372,900 shares $110.08 thousand -63.2%0.2%0.8 $1.51 1/15/2023198,200 shares $287.39 thousand +213.6%0.5%2.2 $1.45 12/30/202263,200 shares $41.71 thousand +21.3%0.2%0.7 $0.66 12/15/202252,100 shares $38.03 thousand -21.7%0.1%0.7 $0.73 11/30/202266,500 shares $56.78 thousand -33.8%0.2%0.8 $0.85 11/15/2022100,400 shares $102.41 thousand -31.6%0.2%1.2 $1.02 10/31/2022146,700 shares $146.70 thousand -16.2%0.3%1.6 $1.00 10/15/2022175,000 shares $184.26 thousand -9.1%0.4%1.4 $1.05 9/30/2022192,600 shares $201.27 thousand -24.0%0.5%0.6 $1.05 9/15/2022253,300 shares $387.55 thousand +15.4%0.6%0.8 $1.53 8/31/2022219,500 shares $318.28 thousand +15.0%0.5%0.7 $1.45 8/15/2022190,800 shares $311.00 thousand -34.3%0.4%0.6 $1.63 7/31/2022290,300 shares $534.15 thousand -39.2%0.7%0.9 $1.84 7/15/2022477,100 shares $620.23 thousand +179.8%1.1%1.5 $1.30 6/30/2022170,500 shares $123.61 thousand -35.5%0.4%1 $0.73 6/15/2022264,400 shares $187.72 thousand -16.5%0.6%1.6 $0.71 5/31/2022316,600 shares $186.13 thousand -25.2%0.8%1.1 $0.59 5/15/2022423,500 shares $249.87 thousand +2.9%1.0%0.9 $0.59 4/30/2022411,600 shares $289.35 thousand -23.3%1.0%0.8 $0.70 4/15/2022536,800 shares $526.06 thousand -22.3%1.3%1 $0.98 3/31/2022690,400 shares $689.71 thousand -15.4%1.6%1.4 $1.00 3/15/2022816,100 shares $697.77 thousand -1.0%1.9%1.6 $0.86 2/28/2022824,300 shares $2.23 million -10.1%1.9%1.8 $2.70 2/15/2022917,100 shares $3.00 million -10.1%2.2%3.4 $3.27 1/31/20221,020,000 shares $2.91 million +4.6%2.4%3.3 $2.85 1/15/2022974,900 shares $2.79 million +15.7%2.3%3 $2.86 12/31/2021842,800 shares $2.01 million -15.4%2.0%2 $2.38 12/15/2021996,300 shares $2.38 million -6.0%2.3%0.5 $2.39 11/30/20211,060,000 shares $2.89 million -6.2%2.5%0.6 $2.73 11/15/20211,130,000 shares $3.24 million -6.6%2.7%0.6 $2.87The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency. 10/29/20211,210,000 shares $2.93 million -19.9%2.8%0.7 $2.42 10/15/20211,510,000 shares $4.03 million +108.9%3.5%0.8 $2.67 9/30/2021723,000 shares $1.87 million -19.0%1.7%0.4 $2.58 9/15/2021892,100 shares $2.15 million -12.5%2.1%2.4 $2.41 8/31/20211,020,000 shares $2.71 million +21.6%2.4%1.9 $2.66 8/13/2021838,700 shares $1.75 million -5.1%2.0%1.3 $2.09 7/30/2021883,400 shares $1.87 million +10.7%2.0%1.3 $2.12 7/15/2021798,300 shares $1.88 million +61.0%1.9%1.3 $2.35 6/30/2021495,900 shares $1.37 million +33.4%1.2%0.8 $2.77 6/15/2021371,700 shares $1.07 million +1.2%0.9%0.7 $2.88 5/28/2021367,200 shares $1.12 million +11.5%0.9%0.8 $3.06 5/14/2021329,200 shares $954.68 thousand +39.3%N/A1.5 $2.90 4/30/2021236,300 shares $1.05 million +47.6%N/A1 $4.43 4/15/2021160,100 shares $707.64 thousand +7.2%N/A0.6 $4.42 3/31/2021149,300 shares $733.06 thousand +24.8%N/A0.3 $4.91 3/15/2021119,600 shares $674.54 thousand +55.7%N/A0.2 $5.64 2/26/202176,800 shares $417.79 thousand +78.6%N/A0.1 $5.44 2/12/202143,000 shares $256.71 thousand -57.7%N/A0.1 $5.97 1/29/2021101,600 shares $572.01 thousand -18.7%N/A0.2 $5.63 1/15/2021124,900 shares $811.85 thousand +157.5%N/A0.3 $6.50 12/31/202048,500 shares $218.74 thousand -19.0%N/A0.2 $4.51 12/15/202059,900 shares $270.15 thousand -18.8%N/A0.3 $4.51 11/30/202073,800 shares $332.10 thousand -40.9%0.3%0.3 $4.50 11/15/2020124,800 shares $590.30 thousand -16.2%0.5%0.6 $4.73 10/30/2020149,000 shares $740.53 thousand -73.1%0.5%0.7 $4.97 10/15/2020553,700 shares $2.71 million -55.4%1.9%2.3 $4.89 9/30/20201,240,000 shares $6.41 million -57.1%4.3%5.4 $5.17 9/15/20202,890,000 shares $15.90 million +1.1%9.6%14.1 $5.50 8/31/20202,860,000 shares $15.84 million +10.0%9.5%24.5 $5.54 NCNA Short Interest - Frequently Asked Questions What is NuCana's current short interest? Short interest is the volume of NuCana shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 61,000 shares of NCNA short. 290.48% of NuCana's shares are currently sold short. Learn More on NuCana's current short interest. What is a good short interest percentage for NuCana? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 290.48% of NuCana's floating shares are currently sold short. Is NuCana's short interest increasing or decreasing? NuCana saw a decline in short interest in July. As of July 31st, there was short interest totaling 61,000 shares, a decline of 99.8% from the previous total of 29,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NuCana's short interest compare to its competitors? 290.48% of NuCana's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NuCana: Genelux Corporation (6.37%), Connect Biopharma Holdings Limited Sponsored ADR (0.08%), IO Biotech, Inc. (1.76%), Protara Therapeutics, Inc. (8.29%), Inhibikase Therapeutics, Inc. (4.58%), OKYO Pharma Limited Sponsored ADR (0.33%), Adagene Inc. Sponsored ADR (0.16%), Scilex Holding Company (8.76%), Tenaya Therapeutics, Inc. (7.89%), Immuneering Corporation (6.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short NuCana stock? Short selling NCNA is an investing strategy that aims to generate trading profit from NuCana as its price is falling. NCNA shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NuCana? A short squeeze for NuCana occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NCNA, which in turn drives the price of the stock up even further. How often is NuCana's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NCNA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Genelux Short Squeeze Connect Biopharma Short Squeeze IO Biotech Short Squeeze Protara Therapeutics Short Squeeze Inhibikase Therapeutics Short Squeeze OKYO Pharma Short Squeeze Adagene Short Squeeze Scilex Short Squeeze Tenaya Therapeutics Short Squeeze Immuneering Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NCNA) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access